112 CC Meeting (10.6.2021)
Total Page:16
File Type:pdf, Size:1020Kb
1 Annexure -2 of Item No.7 (1-239) 112th CC Meeting (10.6.2021) 1. The decision of the PCI are as under. 2. It is decided that decisions are subject to following conditions. a) the consent of affiliation of the Examining Authority and NOC of the State Government (as applicable) should be available with the institution. b) the institution should have a legal entity status on the date of application to PCI and NOC of the State Government and consent of affiliation of Examining Authority (as applicable )shall be in the name of legal entity. c) They shall produce records of their legal entity and the land and building documents to substantiate their claims. d) Wherever needed inspections will be carried out subsequently and if the facts claimed by the institution are found false, the PCI may change or withdraw the approval. e) Any approval granted by the PCI beyond 2021-2022 academic session will stand but will be considered year on year basis based on the information submitted by institution in online SIF. f) Wherever required, institution shall furnish additional information as sought by the PCI from time to time. g) The request for raise in admissions for D.Pharm course beyond 60 intake is not considered as per the policy of the council. h) Regarding M.Pharm seats, it was noted that 110 Central Council in its meeting held on 11th December, 2020 under item No.273 decided as under - i) 12 specialties / subjects are prescribed in which M.Pharm can be conducted. (Ref: Reguation-9., Appendix-A of M.Pharm Regulations). ii) maximum 15 seats per specialization are sanctioned by PCI (Ref: Regulation-23.(1) of M.Pharm Regulations) Further as per the statutory provisions of M.Pharm Regulations, the ratio of recognized Post-Graduate teacher to number of students to be admitted for the M.Pharm course shall be 1:3. iii) as per the procedure in vogue, the institution applies in SIF for number of seats per specialization / raise in admission in case number of seats sanctioned by PCI are less than 15. iv) In view of above statutory provisions of the M.Pharm Regulations, it was decided that in case institution has the prescribed teaching staff with prescribed experience as per “The Master of Pharmacy (M.Pharm) Course Regulations, 2014”, PCI shall sanction number of admissions per M.Pharm specialization based on availability of the teaching staff irrespective of institution’s request in SIF. However, under no circumstances more than 15 students per specialization shall be sanctioned. In view of above, M.Pharm seats are decided accordingly. v) The institution shall not make any admission to the increased intake sanctioned by PCI without affiliation of the Examining Authority for raise in admission. 3. The above conditions be also conveyed to individual institution through the institution’s dash board. 2 A G E N D A I T E M S Assam Item.No. Institute Name/ 112 CC (10.6.2021) Decision Examining Authority/ ID Hospital 1/ AS-17 NEF College Of 1. Granted approval for 2021-2022 The Registrar / 2021- Pharmaceutical academic session for conduct of 2nd Srimanta Sankaradeva 2022 Education And year for 60 admissions for D.Pharm University of Health Research, Village course. Sciences Narakasur Hill Nagaon Sadar, Top Bhangagarh District Nagaon Allowed 60 admissions in 2021-2022 Guwahati Assam 782001 in 1st year (D.Pharm) / PCI – 4454 2. Granted approval for 2021-2022 academic session for conduct of 2nd year for 60 admissions for B.Pharm course. Allowed 60 admissions in 2021-2022 in 1st year (B.Pharm) 3 Item.No. Institute Name/ 112 CC (10.6.2021) Decision Examining Authority/ ID Hospital 2/ AS-18 Royal School of 1. Granted approval for 2021-2022 The Assam Royal Global / 2021- Pharmacy academic session for conduct of 2nd University Betkuchi 2022 Assam Royal year for 60 admissions for D.Pharm Opposit Tirupati Balaji Global University , course. Temple Guwahati Assam NH 37, Betkuchi, Allowed 60 admissions in 2021-2022 KAMRUP st METRO, 781035 in 1 year (D.Pharm) / PCI – 2704 2. Granted approval for 2021-2022 rd academic session for conduct of 3 year for 100 admissions for B.Pharm course. Allowed 100 admissions in 2021-2022 in 1st year (B.Pharm) (Raise in admissions from 60 to 100 from 2020-2021 for B.Pharm course is already approved) Haryana 3/ HR- Department of 1. B.Pharm course is already approved The Registrar Maharishi 126 / Pharmaceutical upto 2024-2025 academic session for Dayanand University 2021- Sciences M D 60 admissions. Rohtak 2022 University Rohtak 124001 2. M.Pharm course – PCI - 433 M.Pharm (Industrial Pharmacy)-10 M.Pharm (Pharmaceutical Chemistry) – 15 M.Pharm (Regulatory Affairs) – 10 M.Pharm (Pharmacology) – 10 M.Pharm (Pharmacognosy)-12 Jharkhand 4 Bharathi 1. Extension of approval upto 2021- D. Pharm Educational Trust 2022 academic session for 60 JH-50/ Bharathi College of admissions for D.Pharm course. Diploma in Pharmacy 2021- Pharmacy Village Examining Committee 2022 Kandri Post 2. Regarding B.Pharm course : It was Deptt of Health Medical Mandar Ranchi noted that Institution has failed to Education and Family 835214 submit consent of affiliation of Welfare Govt of Jharkhand Examining Authority and NOC of Ranchi PCI-245 the State Government for B.Pharm D.Pharm & course for 2021-2022 acedemic B.Pharm session. 4 Item.No. Institute Name/ 112 CC (10.6.2021) Decision Examining Authority/ ID Hospital In view of above it was decided to reject the application for introduction of B.Pharm course. 5 School of 1. It was noted that - D. Pharm & B.Pharm Pharmacy Sai Nath a) D.Pharm course is already JH-51/ University Jirawar approved upto 2022-2023 The Secretary 2021- Chandway Kuchu academic session for 60 Sai Nath University, 2022 Road Thana admissions. Jirawar, Chandway- Ormanjhi Ranchi Kuchu Road, Thana 835 219 b) Sai Nath University, Jirawar, Ormanjhi, Ranchi – 835 Chandway- Kuchu Road, Thana 219 (Jharkhand) Ormanjhi, Ranchi, Jharkhand has PCI-1973 applied to the Council for two D.Pharm & institutions for approval D.Pharm B.Pharm and B.Pharm courses in the name of – i) School of Pharmacy Sai Nath University Jirawar Chandway Kuchu Road Thana Ormanjhi Ranchi, Jharkhand. (PCI-1973) ii) Faculty of Medical Sciences and Research, Sai Nath University Jirawar Chandway Kuchu Road Thana Ormanjhi Ranchi, Jharkhand. (PCI-607) c) institutions have also failed to submit consent of affiliation of Examining Authority for B.Pharm course. 2. In view of above, it was decided to seek – a) clarification from the University as to whether campuses of both above cited institutions are different and there is no sharing of infrastructure like labs., equipments, lecture halls etc. The teaching staff for both the institutions is also different. b) The University shall submit the documentary evidence for the separate infrastructure and teaching staff for the same. 5 Item.No. Institute Name/ 112 CC (10.6.2021) Decision Examining Authority/ ID Hospital 6 Tetri Chandravansi 1. Extension of approval upto 2021- D. Pharm and Pharmacy College, 2022 academic session for 60 12 Nawadih Kala, admissions for D.Pharm course. Diploma in Pharmacy PO+PS- Examining Committee JH-52/ Bishrampur, 2. Grant approval for 2021-2022 Deptt of Health Medical 2021- Palamu-822132 academic session for conduct of 3rd Education and Family 2022 (Jharkhand) year for 60 admissions for B.Pharm Welfare Govt of Jharkhand course. Ranchi (Upto 2020-2021) PCI-2477 Allowed 60 admissions in 2021-2022 D.Pharm in 1st year (B.Pharm). The Registrar, Ramchandra Chandravansi 3. It was noted that institution has University, Nawadihkala, PCI-4171 applied for D.Pharm (PCI-2477) and PO and PS-Bishranpur, B.Pharm B.Pharm (PCI-4171) course with Palamu-822132 separate ID. (Jharkhand) (w.e.f. 2021-2022) It was further decided to instruct the institution to apply with one ID. It was further decided to write NIC in the matter. 4. It was further decided to approve the Change of Examining Authority from 2021-2022 academic session subject to submission of the disaffiliation letter from old examining authority. From Diploma in Pharmacy Examining Committee Deptt of Health Medical Education and Family Welfare Govt of Jharkhand Ranchi To The Registrar, Ramchandra Chandravansi University, Nawadihkala, PO and PS- Bishranpur, Palamu-822132 (Jharkhand) 6 Item.No. Institute Name/ 112 CC (10.6.2021) Decision Examining Authority/ ID Hospital 7 Faculty of Medical 1. It was noted that - D. Pharm &. B.Pharm Science and a) D.Pharm course is already JH-60/ Reserch Sai Nath The Secretary, approved upto 2020-2021 Sai Nath University, 2021- University Jirawar academic session for 60 2022 Chandway Kuchu Jirawar, Chandway-Kuchu admissions. Road, Road Thana Ormanjhi Ranchi b) Sai Nath University, Jirawar, Thana Ormanjhi, Ranchi – Chandway- Kuchu Road, Thana 835 219 (Jharkhand) Ormanjhi, Ranchi, Jharkhand has PCI-607 applied to the Council for two D.Pharm & institutions for approval D.Pharm B.Pharm course and B.Pharm courses in the name of – i) School of Pharmacy Sai Nath University Jirawar Chandway Kuchu Road Thana Ormanjhi Ranchi, Jharkhand. (PCI-1973) ii) Faculty of Medical Sciences and Research, Sai Nath University Jirawar Chandway Kuchu Road Thana Ormanjhi Ranchi, Jharkhand. (PCI-607) c) institutions have also failed to submit consent of affiliation of Examining Authority for B.Pharm course. 2. In view of above, it was decided to seek – a) clarification from the University as to whether campuses of both above cited institutions are different and there is no sharing of infrastructure like labs., equipments, lecture halls etc. The teaching staff for both the institutions is also different. b) The University shall submit the documentary evidence for the separate infrastructure and teaching staff for the same.